Literature DB >> 25770193

Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.

Heloisa Helena Milioli1, Karla Santos Sousa1, Rodrigo Kaviski1, Nayara Cristina Dos Santos Oliveira1, Cícero De Andrade Urban2, Rubens Silveira De Lima3, Iglenir João Cavalli1, Enilze Maria De Souza Fonseca Ribeiro1.   

Abstract

BACKGROUND: Lymph node metastasis is an important clinicopathological parameter for breast cancer prognostication and treatment. Although the development of metastasis is common in axillary lymph nodes, the mechanisms underlying the locoregional spread are yet poorly understood. In the present study, we outline the involvement of proteins in tumor invasion by comparing the proteome profile of primary breast tumors (PBT) against that of lymph node metastasis (LNM). PATIENTS AND METHODS: The comparative proteome analyses of seven paired samples were performed using two-dimensional gel electrophoresis (2DE) and mass spectrometry (MS).
RESULTS: Recurrent proteins were differentially expressed in PBT and LNM across patients. Higher levels of 1433G, 1433T, K2C8, PSME2, SNAA, TPM4, TRFE and VIME were observed in primary tumors compared to the metastatic site. On the other hand, higher levels of ALDH2 and GDIR2 were identified in metastasis related to tumors. These proteins provide a new insight on breast cancer research.
CONCLUSION: Our achievements strengthened previous omics-based studies and also support the validation of potential markers of tumor invasion and metastasis. Copyright
© 2015, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  2D PAGE; MALDI-ToF; Proteomics; breast cancer; lymph node; markers; mass spectrometry; metastasis; tumour invasion

Mesh:

Substances:

Year:  2015        PMID: 25770193

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  8 in total

1.  Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.

Authors:  Xue Zhou; Xiaowei Zhu; Junchao Yao; Xue Wang; Ning Wang
Journal:  Invest New Drugs       Date:  2021-05-13       Impact factor: 3.850

2.  Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients.

Authors:  Stuart A Savill; Helen F Leitch; John N Harvey; Trevor H Thomas
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

3.  Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.

Authors:  Claudia Cava; Gloria Bertoli; Antonio Colaprico; Catharina Olsen; Gianluca Bontempi; Isabella Castiglioni
Journal:  BMC Genomics       Date:  2018-01-06       Impact factor: 3.969

Review 4.  A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.

Authors:  Sara S Faria; Carlos F M Morris; Adriano R Silva; Micaella P Fonseca; Patrice Forget; Mariana S Castro; Wagner Fontes
Journal:  Front Oncol       Date:  2017-02-20       Impact factor: 6.244

5.  Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy.

Authors:  Xiaoyun Wang; Fengbo Wu; Yutong Deng; Jinlong Chai; Yuehua Zhang; Gu He; Xiang Li
Journal:  Int J Oncol       Date:  2021-11-15       Impact factor: 5.650

6.  MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.

Authors:  Juliana Pereira Lopes Gonçalves; Christine Bollwein; Anna Melissa Schlitter; Mark Kriegsmann; Anne Jacob; Wilko Weichert; Kristina Schwamborn
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

7.  Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.

Authors:  Matt R Paul; Nicholas P Levitt; David E Moore; Patricia M Watson; Robert C Wilson; Chadrick E Denlinger; Dennis K Watson; Paul E Anderson
Journal:  BMC Genomics       Date:  2016-03-31       Impact factor: 3.969

8.  Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma.

Authors:  Liang Yang; Xiao-Wen Wang; Li-Ping Zhu; Hong-Li Wang; Bin Wang; Qian Zhao; Xi-Yan Wang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.